clinical trial · NCT07278310
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
MiRus·N/A·recruiting·n = 1,025
Symptomatic Severe Native Aortic StenosisAortic StenosisTAVR DeviceSiegel TAVR Device
brief summary
To evaluate the safety and efficacy of Siegel™ TAVR System in the treatment of subjects with symptomatic severe native aortic stenosis.
started
Apr 1, 2026
primary completion
Apr 1, 2028
completion
Apr 1, 2028
last updated
Apr 9, 2026
detailed description
The primary objective is to assess the acute and long-term safety and efficacy of the Siegel THV device in adult subjects with symptomatic, severe native calcific aortic stenosis eligible for the transcatheter aortic valve replacement.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol